Hepagam B Market Report 2026
Download Free Sample Buy Now
Hepagam B Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Hepagam B Market Report 2026

Epidemiology, Pipeline Analysis, Market Insights & Forecasts

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Hepagam B Market Overview

• The Hepagam B market growth in the historic period has been driven by global hepatitis b prevalence, established role of immune globulins

• Market expansion is supported by strengthening public health policies, rising healthcare worker safety measures

• Growth Driver: Rising Hepatitis B Prevalence To Fuel Growth Of Market

• Market Trend: Expansion Of Plasma Collection Centers To Strengthen Position In Market

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Hepagam B Market?

HepaGam B is a human hepatitis B immune globulin used to prevent hepatitis B infection in individuals exposed to the virus, such as healthcare workers or newborns of infected mothers. It provides passive immunity by delivering antibodies against hepatitis B surface antigens. Typically, it is administered via injection and is part of post-exposure prophylaxis.

The main types of hepagam B products are immunoglobulin preparations, vaccines, and antiviral therapies. Immunoglobulin preparations are plasma-derived products containing antibodies that provide passive immunity against specific infections. It is used for post-exposure prophylaxis and chronic hepatitis b treatment and is distributed through hospital pharmacies, retail pharmacies, and online pharmacies.

Hepagam B Market Global Report 2026 Market Report bar graph

What Is The Hepagam B Market Size and Share 2026?

The growth in the historic period can be attributed to global hepatitis b prevalence, established role of immune globulins, hospital adoption for exposure management, vaccination program gaps, occupational exposure risks.

What Is The Hepagam B Market Growth Forecast?

The growth in the forecast period can be attributed to strengthening public health policies, rising healthcare worker safety measures, increased screening programs, growth in hospital based prophylaxis, global hepatitis elimination initiatives. Major trends in the forecast period include rising demand for post exposure prophylaxis, increased focus on maternal neonatal protection, expansion of immunoglobulin therapies, growing awareness of hepatitis b prevention, improved infection control protocols.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Hepagam B Market Segmentation

1) By Product Type: Immunoglobulin Preparations, Vaccines, Antiviral Therapies

2) By Indication: Post-Exposure Prophylaxis, Chronic Hepatitis B Treatment

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What Are The Drivers Of The Hepagam B Market?

The increasing prevalence of hepatitis B is expected to boost the growth of the hepagam B market going forward. Hepatitis B infections are liver infections caused by the hepatitis B virus (HBV), potentially leading to chronic disease, cirrhosis, or liver cancer. Hepatitis B infections are rising due to inadequate vaccination coverage, increased transmission in high-risk populations, and lack of awareness about preventive measures. HepaGam B is used to prevent hepatitis B infection by providing passive immunity in individuals exposed to the virus. For instance, in April 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, an estimated 254 million people worldwide were living with chronic hepatitis B infection in 2022, with 1.2 million new cases reported each year. The disease led to approximately 1.1 million deaths, primarily due to cirrhosis and hepatocellular carcinoma (primary liver cancer). Therefore, the increasing prevalence of Hepatitis B will drive the hepagam B industry.

The increasing healthcare spending is expected to accelerate the growth of the hepagam B market. Healthcare spending is rising due to factors such as aging populations, increasing prevalence of chronic diseases, advancements in medical technology, and higher demand for quality care. Rising healthcare expenditure supports hepagam B by enabling greater investment in preventive treatments, improved access to immunoglobulin therapies, and better management of hepatitis B-related complications. For instance, in April 2024, according to the World Health Organization, a Switzerland-based government department, global health strategies aim to ensure that 80% of individuals living with chronic hepatitis B and C receive treatment by 2030. Therefore, the increasing healthcare spending will drive the growth of the hepagam B industry.

Key Players In The Global Hepagam B Market

Major companies operating in the hepagam b market are Kamada Ltd., Kibiopharma Inc., Emergent BioSolutions Inc.

Global Hepagam B Market Trends and Insights

The key trend in the hepagam B market is focusing on the expansion of plasma collection centers to gain a competitive edge in the industry. Plasma collection is the process of extracting plasma from a donor's blood, which is used for various medical treatments, including the production of immunoglobulins and clotting factor therapies. For instance, in September 2024, Kamada Limited, an Israel-based biopharmaceutical company, announced the opening of a new plasma collection center in Houston, Texas, aimed at enhancing its operations in specialty plasma collection. This 12,000 square foot facility is expected to support over 50 donor beds and achieve an annual collection capacity of approximately 50,000 liters. The center will focus on collecting both normal source plasma and specialty plasma, contributing an estimated $8 million to $10 million in annual revenue at full capacity. This expansion aligns with Kamada's strategy to become a leading global player in the specialty plasma-derived market.

Need data on a specific region in this market?
Request Regional Data

Regional Insights

North America was the largest region in the hepagam B market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Hepagam B Market?

The hepagam B market consists of sales of hepatitis B vaccines, intravenous immunoglobulin, subcutaneous immunoglobulin, and hepatitis A immunoglobulin. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Hepagam B Market Report 2026?

The hepagam b market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the hepagam b industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Hepagam B Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $ billion
Revenue Forecast In 2035 $ billion
Growth Rate No CAGR found from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Product Type, Indication, Distribution Channel
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Kamada Ltd., Kibiopharma Inc., Emergent BioSolutions Inc.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Hepagam B Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Hepagam B Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Hepagam B Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Hepagam B Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Rising Demand For Post Exposure Prophylaxis

4.2.2 Increased Focus On Maternal Neonatal Protection

4.2.3 Expansion Of Immunoglobulin Therapies

4.2.4 Growing Awareness Of Hepatitis B Prevention

4.2.5 Improved Infection Control Protocols

5. Hepagam B Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Maternity Care Centers

5.3 Transplant Centers

5.4 Emergency Care Units

5.5 Public Health Clinics

6. Hepagam B Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Hepagam B Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Hepagam B PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Hepagam B Market Size, Comparisons And Growth Rate Analysis

7.3. Global Hepagam B Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Hepagam B Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Hepagam B Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Hepagam B Market Segmentation

9.1. Global Hepagam B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Immunoglobulin Preparations, Vaccines, Antiviral Therapies

9.2. Global Hepagam B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Post-Exposure Prophylaxis, Chronic Hepatitis B Treatment

9.3. Global Hepagam B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

10. Hepagam B Market Regional And Country Analysis

10.1. Global Hepagam B Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Hepagam B Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Hepagam B Market

11.1. Asia-Pacific Hepagam B Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Hepagam B Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Hepagam B Market

12.1. China Hepagam B Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Hepagam B Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Hepagam B Market

13.1. India Hepagam B Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Hepagam B Market

14.1. Japan Hepagam B Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Hepagam B Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Hepagam B Market

15.1. Australia Hepagam B Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. South Korea Hepagam B Market

16.1. South Korea Hepagam B Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

16.2. South Korea Hepagam B Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Western Europe Hepagam B Market

17.1. Western Europe Hepagam B Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. Western Europe Hepagam B Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. UK Hepagam B Market

18.1. UK Hepagam B Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Germany Hepagam B Market

19.1. Germany Hepagam B Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. France Hepagam B Market

20.1. France Hepagam B Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Eastern Europe Hepagam B Market

21.1. Eastern Europe Hepagam B Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

21.2. Eastern Europe Hepagam B Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. North America Hepagam B Market

22.1. North America Hepagam B Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

22.2. North America Hepagam B Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. USA Hepagam B Market

23.1. USA Hepagam B Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

23.2. USA Hepagam B Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Canada Hepagam B Market

24.1. Canada Hepagam B Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

24.2. Canada Hepagam B Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. South America Hepagam B Market

25.1. South America Hepagam B Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

25.2. South America Hepagam B Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Middle East Hepagam B Market

26.1. Middle East Hepagam B Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Middle East Hepagam B Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Africa Hepagam B Market

27.1. Africa Hepagam B Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

27.2. Africa Hepagam B Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Hepagam B Market Regulatory and Investment Landscape

29. Hepagam B Market Competitive Landscape And Company Profiles

29.1. Hepagam B Market Competitive Landscape And Market Share 2024

29.1.1. Top 10 Companies (Ranked by revenue/share)

29.2. Hepagam B Market - Company Scoring Matrix

29.2.1. Market Revenues

29.2.2. Product Innovation Score

29.2.3. Brand Recognition

29.3. Hepagam B Market Company Profiles

29.3.1. Kamada Ltd. Overview, Products and Services, Strategy and Financial Analysis

29.3.2. Kibiopharma Inc. Overview, Products and Services, Strategy and Financial Analysis

29.3.3. Emergent BioSolutions Inc. Overview, Products and Services, Strategy and Financial Analysis

30. Global Hepagam B Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Hepagam B Market

32. Hepagam B Market High Potential Countries, Segments and Strategies

32.1 Hepagam B Market In 2030 - Countries Offering Most New Opportunities

32.2 Hepagam B Market In 2030 - Segments Offering Most New Opportunities

32.3 Hepagam B Market In 2030 - Growth Strategies

32.3.1 Market Trend Based Strategies

32.3.2 Competitor Strategies

33. Appendix

33.1. Abbreviations

33.2. Currencies

33.3. Historic And Forecast Inflation Rates

33.4. Research Inquiries

33.5. The Business Research Company

33.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Hepagam B Market, Overview Of Key Products - Product Examples
  • Table 2: Global Hepagam B Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Hepagam B Market, Supply Chain Analysis
  • Table 4: Global Hepagam B Market, Major Raw Material Providers
  • Table 5: Global Hepagam B Market, Major Resource Providers
  • Table 6: Global Hepagam B Market, Major Manufacturers (Suppliers)
  • Table 7: Global Hepagam B Market, Major Distributors And Channel Partners
  • Table 8: Global Hepagam B Market, Key Technologies & Future Trends
  • Table 9: Global Hepagam B Market, Major Trends
  • Table 10: Global Hepagam B Market, Major End Users
  • Table 11: Global Hepagam B Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Hepagam B Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Hepagam B Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Hepagam B Market - TAM, US$ Billion, 2025
  • Table 15: Global Hepagam B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Hepagam B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Hepagam B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Hepagam B Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Hepagam B Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Asia-Pacific, Hepagam B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Asia-Pacific, Hepagam B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, Hepagam B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: China, Hepagam B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: China, Hepagam B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, Hepagam B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: India, Hepagam B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: India, Hepagam B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, Hepagam B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: Japan, Hepagam B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: Japan, Hepagam B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, Hepagam B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Australia, Hepagam B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Australia, Hepagam B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, Hepagam B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: South Korea, Hepagam B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: South Korea, Hepagam B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: South Korea, Hepagam B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Western Europe, Hepagam B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Western Europe, Hepagam B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Western Europe, Hepagam B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: UK, Hepagam B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: UK, Hepagam B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: UK, Hepagam B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Germany, Hepagam B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Germany, Hepagam B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Germany, Hepagam B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: France, Hepagam B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: France, Hepagam B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: France, Hepagam B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Eastern Europe, Hepagam B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Eastern Europe, Hepagam B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Eastern Europe, Hepagam B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: North America, Hepagam B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: North America, Hepagam B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: North America, Hepagam B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: USA, Hepagam B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: USA, Hepagam B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: USA, Hepagam B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Canada, Hepagam B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Canada, Hepagam B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Canada, Hepagam B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: South America, Hepagam B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: South America, Hepagam B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: South America, Hepagam B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Middle East, Hepagam B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Middle East, Hepagam B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Middle East, Hepagam B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Africa, Hepagam B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Africa, Hepagam B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Africa, Hepagam B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Global Hepagam B Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 72: Global Hepagam B Market - Company Scoring Matrix
  • Table 73: Kamada Ltd. Financial Performance
  • Table 74: Kibiopharma Inc. Financial Performance
  • Table 75: Emergent BioSolutions Inc. Financial Performance
  • Table 76: Global Hepagam B Market, Competitive Benchmarking (In USD Billions)
  • Table 77: Global Hepagam B Market, Competitive Dashboard
  • Table 78: Global Hepagam B Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 79: Global, Hepagam B Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030
  • Table 80: Global, Hepagam B Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030
  • Table 81: Global, Hepagam B Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

List Of Figures

    Figure 1: Global Hepagam B Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Hepagam B Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Hepagam B Market, Supply Chain Analysis
  • Figure 4: Global Hepagam B Market, Major Raw Material Providers
  • Figure 5: Global Hepagam B Market, Major Resource Providers
  • Figure 6: Global Hepagam B Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Hepagam B Market, Major Distributors And Channel Partners
  • Figure 8: Global Hepagam B Market, Key Technologies & Future Trends
  • Figure 9: Global Hepagam B Market, Major Trends
  • Figure 10: Global Hepagam B Market, Major End Users
  • Figure 11: Global Hepagam B Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Hepagam B Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Hepagam B Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Hepagam B Market - TAM, US$ Billion, 2025
  • Figure 15: Global Hepagam B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Hepagam B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Hepagam B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Hepagam B Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Hepagam B Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Asia-Pacific, Hepagam B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Asia-Pacific, Hepagam B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, Hepagam B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: China, Hepagam B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: China, Hepagam B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, Hepagam B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: India, Hepagam B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: India, Hepagam B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, Hepagam B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: Japan, Hepagam B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: Japan, Hepagam B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, Hepagam B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Australia, Hepagam B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Australia, Hepagam B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, Hepagam B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: South Korea, Hepagam B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: South Korea, Hepagam B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: South Korea, Hepagam B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Western Europe, Hepagam B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Western Europe, Hepagam B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Western Europe, Hepagam B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: UK, Hepagam B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: UK, Hepagam B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: UK, Hepagam B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Germany, Hepagam B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Germany, Hepagam B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Germany, Hepagam B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: France, Hepagam B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: France, Hepagam B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: France, Hepagam B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Eastern Europe, Hepagam B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Eastern Europe, Hepagam B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Eastern Europe, Hepagam B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: North America, Hepagam B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: North America, Hepagam B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: North America, Hepagam B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: USA, Hepagam B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: USA, Hepagam B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: USA, Hepagam B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Canada, Hepagam B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Canada, Hepagam B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Canada, Hepagam B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: South America, Hepagam B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: South America, Hepagam B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: South America, Hepagam B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Middle East, Hepagam B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Middle East, Hepagam B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Middle East, Hepagam B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Africa, Hepagam B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Africa, Hepagam B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Africa, Hepagam B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Global Hepagam B Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 72: Global Hepagam B Market - Company Scoring Matrix
  • Figure 73: Kamada Ltd. Financial Performance
  • Figure 74: Kibiopharma Inc. Financial Performance
  • Figure 75: Emergent BioSolutions Inc. Financial Performance
  • Figure 76: Global Hepagam B Market, Competitive Benchmarking (In USD Billions)
  • Figure 77: Global Hepagam B Market, Competitive Dashboard
  • Figure 78: Global Hepagam B Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 79: Global, Hepagam B Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030
  • Figure 80: Global, Hepagam B Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030
  • Figure 81: Global, Hepagam B Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Hepatorenal Syndrome Treatment Market Report 2026 - Global Outlook – By Type (Type 1 Hepatorenal Syndrome, Type 2 Hepatorenal Syndrome), By Treatment (Therapeutics, Surgical Treatment), By End-User (Hospitals And Clinics...

Chronic Hepatitis B Market Report 2026 - Global Outlook – By Drug Class (Antivirals, Immune Modulators), By Gender (Male, Female), By Distribution Channel (Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online P...

Hexane Market Report 2026 - Global Outlook – By Type (N-Hexane, Isohexane, Neohexane), By Grade (Polymer Grade, Food Grade, Other Grades), By Application (Industrial Solvents, Edible Oil Extractant, Adhesives and Sealant...

Heparin Market Report 2026 - Global Outlook – By Product (Unfractionated Heparin, Low Molecular Weight Heparin (LMWH), Ultra-Low Molecular Weight Heparin (ULMWH)), By Source (Bovine, Porcine), By Route of Administration ...

Hepatitis B Virus (HBV) Market Report 2026 - Global Outlook – By Type (Acute, Chronic), By Treatment (Immune Modulator Drugs, Antiviral Drugs, Vaccine, Surgery), By Age Group (Pediatrics, Adults, Seniors), By End User (M...

Trade Finance Market Report 2026 - Global Outlook – By Type (Supply Chain Finance, Structured Trade Finance, Traditional Trade Finance), By Service Provider (Banks, Financial Institutions, Trading Houses, Other Services)...

Heptanoic Acid Market Report 2026 - Global Outlook – By Grade (Pharmaceutical Grade, Industrial Grade), By Application (Cosmetic, Flavors and Fragrance, Chemical Synthesis, Other Applications), By End-Users (Automotive, ...

Hepatitis Therapeutics Market Report 2026 - Global Outlook – By Disease Type (Hepatitis A, Hepatitis B, Hepatitis C, Other Disease Types), By Drug Class (Oral Antivirals, Immune Modulators), By Distribution Channel (Hosp...

Frequently Asked Questions

The Hepagam B market was valued at $ billion in 2025, increased to $ billion in 2026, and is projected to reach $ billion by 2030.

The global Hepagam B market is expected to grow at a CAGR of nan% from 2026 to 2035 to reach $ billion by 2035.

Some Key Players in the Hepagam B market Include, Kamada Ltd., Kibiopharma Inc., Emergent BioSolutions Inc. .

Major trend in this market includes: Expansion Of Plasma Collection Centers To Strengthen Position In Market. For further insights on this market. request a sample here

North America was the largest region in the hepagam B market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepagam b market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us